These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28838692)

  • 1. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
    Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.
    Reddy ST; Mendonza JJ; Makani VKK; Bhadra MP; Uppuluri VM
    Bioorg Chem; 2020 Dec; 105():104374. PubMed ID: 33130349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent.
    Mokale SN; Sakle NS; Bhavale SA; Lokwani DK; Shelke VR
    Anticancer Agents Med Chem; 2018; 18(7):1009-1015. PubMed ID: 29189180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.
    Çalışkan B; Sinoplu E; İbiş K; Akhan Güzelcan E; Çetin Atalay R; Banoglu E
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1352-1361. PubMed ID: 30251900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
    Naresh Kumar R; Jitender Dev G; Ravikumar N; Krishna Swaroop D; Debanjan B; Bharath G; Narsaiah B; Nishant Jain S; Gangagni Rao A
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2927-2930. PubMed ID: 27130357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
    Lobo MM; Viau CM; Dos Santos JM; Bonacorso HG; Martins MA; Amaral SS; Saffi J; Zanatta N
    Eur J Med Chem; 2015 Aug; 101():836-42. PubMed ID: 26275603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
    Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
    Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
    Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
    Im D; Jung K; Yang S; Aman W; Hah JM
    Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
    Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
    Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, conformation and antiproliferative activity of isothiazoloisoxazole 1,1-dioxides.
    Blackburn J; Molyneux G; Pitard A; Rice CR; Page MI; Afshinjavid S; Javid FA; Coles SJ; Horton PN; Hemming K
    Org Biomol Chem; 2016 Feb; 14(6):2134-44. PubMed ID: 26762685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation.
    Liu SJ; Zhao Q; Peng C; Mao Q; Wu F; Zhang FH; Feng QS; He G; Han B
    Eur J Med Chem; 2021 May; 217():113359. PubMed ID: 33725632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
    Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
    Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
    Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
    Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.
    İbiş K; Nalbat E; Çalışkan B; Kahraman DC; Cetin-Atalay R; Banoglu E
    Eur J Med Chem; 2021 Oct; 221():113489. PubMed ID: 33951549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.